ARCHIVES

DeVita Changes Mind On OSP Phase Out Reasons, But Presses for “Internalizing” Coordinating Portfolio

This article is from The Cancer Letter archive.

Vol. 14 No. 01 | January 1, 1988

Download PDF Visit The Full Archive

Related Articles

Fake Avastin, Paid for by Medicare, Administered to U.S. Patients

October 3, 2014

‘Meta-analysis’ Of Early Breast Cancer Trials finds Adjuvant Therapy Significantly Prolongs Life

January 10, 1992

House Passes Bill Giving FDA Authority Over Tobacco Products

April 10, 2009

Study Finds Trial Results Reliable At Three Years

July 29, 2005

McGivney Out at NCCN as Board Cites Management Style, Strategic Direction

January 13, 2012

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

March 12, 2010